Patents by Inventor Martin Boyer

Martin Boyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12245948
    Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: March 11, 2025
    Assignee: ExsoMed Corporation
    Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
  • Publication number: 20230200876
    Abstract: A four corner fusion system can include a curved plate that is more aligned with the natural anatomy of the wrist joint, and/or fewer number of screws (for example, about three or four screws). The system can have a lower profile, resulting in less soft tissue impingement. A surgical tool with a pair of offsetting clamping arms can be used to aid in bone reduction during a wrist fusion procedure.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 29, 2023
    Inventors: Martin Boyer, Kathleen McKeon, Kavi Sachar, Andrew J. Leither, Michael Zwolinski
  • Publication number: 20230063432
    Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.
    Type: Application
    Filed: July 12, 2022
    Publication date: March 2, 2023
    Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
  • Patent number: 11413155
    Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: August 16, 2022
    Assignee: Exsomed Corporation
    Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
  • Publication number: 20190307570
    Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.
    Type: Application
    Filed: April 10, 2019
    Publication date: October 10, 2019
    Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
  • Patent number: 8580262
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: November 12, 2013
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Publication number: 20130095498
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: July 16, 2012
    Publication date: April 18, 2013
    Applicant: ID BIOMEDICAL CORPORATION OF QUEBEC
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Patent number: 8309096
    Abstract: Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: November 13, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Normand Blais, Martine Boyer, Vincent Brichard, Jamila Louahed, Denis Martin, Remi Palmantier, Clement Rioux
  • Patent number: 8226953
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: July 24, 2012
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Bernard R. Brodeur, Clement Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Publication number: 20110182923
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: December 28, 2010
    Publication date: July 28, 2011
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Patent number: 7914794
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: March 29, 2011
    Assignee: ID Biomedical Corporation
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Patent number: 7811585
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 9, 2007
    Date of Patent: October 12, 2010
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Patent number: 7740870
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: June 22, 2010
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • Publication number: 20100029912
    Abstract: Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.
    Type: Application
    Filed: July 15, 2009
    Publication date: February 4, 2010
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Normand Blais, Martine Boyer, Vincent Brichard, Jamila Louahed, Denis Martin, Remi Palmantier, Clement Rioux
  • Publication number: 20090042794
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: June 9, 2008
    Publication date: February 12, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Martine Boyer
  • Publication number: 20080227706
    Abstract: Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: January 22, 2008
    Publication date: September 18, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee Hamel, Bernard R. Brodeur
  • Patent number: 7393536
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: July 1, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • Patent number: 7335368
    Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: February 26, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josée Hamel, Bernard R Brodeur
  • Publication number: 20080038268
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: July 9, 2007
    Publication date: February 14, 2008
    Applicant: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Patent number: 7247308
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: July 24, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer